Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions?
Genetic inactivation of PERK signaling in mouse oligodendrocytes: Normal developmental myelination with increased susceptibility to inflammatory demyelination.
Familial clustering in Italian progressive-onset and bout-onset multiple sclerosis.
Gene therapy with Mitochondrial Heat Shock Protein 70 Suppresses Visual Loss and Optic Atrophy in Experimental Autoimmune Encephalomyelitis.
Corticosteroids for treating optic neuritis.
miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4(+) T lymphocytes of patients with relapsing-remitting multiple sclerosis.
Editorial: Plasticity in Multiple Sclerosis: From Molecular to System Level, from Adaptation to Maladaptation.
B cell-directed therapies in multiple sclerosis.
Is environmental radon gas associated with the incidence of neurodegenerative conditions? A retrospective study of multiple sclerosis in radon affected areas in England and Wales.
A critical period for social experience-dependent oligodendrocyte maturation and myelination.
MS14 Down-regulates Lipocalin2 Expression in Spinal Cord Tissue in an Animal Model of Multiple Sclerosis in female C57BL/6.
Neurobiology: Myelin Goes Where the Action Is.
Considerations on the appropriateness of the John Cunningham virus antibody assay use in patients with rheumatoid arthritis.
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
Your client has multiple sclerosis: understanding the challenge.
Role Preferences of People with Multiple Sclerosis: Image-Revised, Computerized Self-Administered Version of the Control Preference Scale.
Galectin-9 is Up-regulated in Astrocytes by TNF and Promotes Encephalitogenic T-cell Apoptosis.
Current and new directions in MRI in multiple sclerosis.
Duloxetine Is Effective in Treating Depression in Multiple Sclerosis Patients: An Open-Label Multicenter Study.
Myelin inhibits oligodendroglial maturation and regulates oligodendrocytic transcription factor expression.
Diffuse cauda equina enhancement in a middle aged male with Susac syndrome and symptomatic cauda equina syndrome.
Age of the Donor Reduces the Ability of Human Adipose-Derived Stem Cells to Alleviate Symptoms in the Experimental Autoimmune Encephalomyelitis Mouse Model.
Disclosure of diagnosis of multiple sclerosis in the workplace positively affects employment status and job tenure.
The gateway theory: How regional neural activation creates a gateway for immune cells via an inflammation amplifier.
The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases.
Pages
« first
‹ previous
…
514
515
516
517
518
519
520
521
522
…
next ›
last »